Personal Genome Diagnostics (PGDx) is a company engaged in precision oncology diagnostics. It develops a portfolio of regulated tissue-based and liquid biopsy genomic products for laboratories. The company specializes in high-throughput next-generation sequencing, proprietary algorithms to identify alterations in complex cancer genomes, and development of technologies for non-invasive approaches in cancer.